Viewing Study NCT06625684



Ignite Creation Date: 2024-10-26 @ 3:41 PM
Last Modification Date: 2024-10-26 @ 3:41 PM
Study NCT ID: NCT06625684
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-25

Brief Title: Key Longitudinal Associations With Risk and Glioblastoma Outcomes
Sponsor: None
Organization: None

Study Overview

Official Title: Key Longitudinal Associations With Risk and Glioblastoma Outcomes
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Key LARGO
Brief Summary: The goal of this observational study is to find out what factors affect the health and risks in adults with glioblastoma GBM a grade 4 brain cancer

The main questions it aims to answer are

How do genetic and immune system factors impact survival and quality of life in GBM patients
What occupational and medical history factors are linked to the risk of getting GBM

Participants will

Fill out an online survey about their medical history and lifestyle

Participants will have the chance to give a blood sample from the outer arm for genetic and immune system testing Blood samples will be given using a home collection kit provided by the study team
Detailed Description: This observational study aims to investigate the various factors influencing outcomes and risks in adults diagnosed with glioblastoma GBM Glioblastoma is a highly aggressive and malignant brain tumor and understanding the factors that affect patient outcomes is crucial for improving management strategies and patient care

The study employs a case-only design where participants will be followed over time to observe how different factors affect their health outcomes Participants will be selected based on their diagnosis of glioblastoma and will be included in the study regardless of current treatment status or disease stage

Findings from this study are expected to provide valuable insights into the factors affecting glioblastoma outcomes and may contribute to the development of personalized treatment strategies and risk assessment tools for better management of the disease

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None